Encompass Health COO reports tax withholding trades

Encompass Health Corp EVP and COO Patrick William Tuer reported two tax-related share dispositions tied to restricted stock vesting.

Rhea-AI Filing Summary

Encompass Health Corp EVP and COO Patrick William Tuer reported two tax-related share dispositions tied to restricted stock vesting. On February 19, 2026, 3,193 shares of Encompass Health common stock were withheld at $107.15 per share to cover tax obligations. On February 20, 2026, an additional 405 shares were withheld at $106.55 per share for the same purpose. After these non-open-market transactions, Tuer directly owned 26,488 shares of Encompass Health common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 3,598 shares

Exercise Price or Tax Liability 2 txns

Insider Tuer Patrick William

Role EVP, Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	405	$106.55	$43K
Exercise Price or Tax Liability	Encompass Health Common Stock	3,193	$107.15	$342K

Holdings After Transaction: Encompass Health Common Stock — 26,488 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

What insider transactions did Encompass Health (EHC) report for Patrick William Tuer?

Encompass Health reported that EVP and COO Patrick William Tuer had shares withheld in two Form 4 transactions to pay tax obligations from restricted stock vesting, rather than executing open-market sales. These were coded as tax-withholding dispositions under transaction code F.

How many Encompass Health (EHC) shares were withheld for Patrick Tuer’s taxes?

Two withholding events were disclosed. On February 19, 2026, 3,193 Encompass Health common shares were withheld. On February 20, 2026, an additional 405 shares were withheld. Both transactions were to satisfy tax withholding obligations from vesting restricted stock awards.

At what prices were Encompass Health (EHC) shares withheld for Patrick Tuer?

The filing shows tax-withholding dispositions at two prices. On February 19, 2026, 3,193 shares were valued at $107.15 per share. On February 20, 2026, 405 shares were valued at $106.55 per share, reflecting the market value used for the withholding.

Did Patrick Tuer sell Encompass Health (EHC) shares on the open market?

The Form 4 indicates no open-market sales. Both transactions are coded F, described as payment of tax liability by delivering securities. A footnote explains the shares were withheld or surrendered solely to cover tax obligations from restricted stock vesting.

How many Encompass Health (EHC) shares does Patrick Tuer own after these transactions?

After the February 20, 2026 tax-withholding disposition, Patrick William Tuer directly owned 26,488 shares of Encompass Health common stock. This figure reflects his holdings following the reported restricted stock vesting-related withholding events in the Form 4.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Transaction code F denotes payment of an exercise price or tax liability by delivering securities. In this case, it reflects Encompass Health shares being withheld or surrendered from restricted stock vesting to cover Patrick Tuer’s tax withholding obligations, not discretionary selling.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 03:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuer Patrick William

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/19/2026		F		3,193(1)	D	$107.15	26,893	D
Encompass Health Common Stock	02/20/2026		F		405(1)	D	$106.55	26,488	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Patrick W. Tuer	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.